Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACLX | AZN | AMGN | GILD | BMY |
| Company | Arcellx Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 114.42 | 193.96 | 368.24 | 146.52 | 60.13 |
| High | 114.62 | 193.96 | 368.78 | 146.71 | 60.81 |
| Low | 114.40 | 190.95 | 359.80 | 143.27 | 59.59 |
| Latest | 114.52 | 191.29 | 361.13 | 144.40 | 59.71 |
| Change | +0.01 | -0.72 | -5.12 | -0.81 | unch |
| % Change | +0.01% | -0.37% | -1.40% | -0.56% | unch |
| Volume | 691,900 | 1,455,500 | 2,334,300 | 3,887,900 | 14,258,000 |
| 20-Day Average Volume | 4,667,205 | 1,937,280 | 2,504,325 | 6,340,045 | 12,243,109 |
| Previous Close | 114.51 | 192.01 | 366.25 | 145.21 | 59.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 107.03 | 199.95 | 375.73 | 147.44 | 60.67 |
| 20-Day Raw Stochastic | 99.46% | 8.30% | 4.22% | 12.91% | 30.44% |
| 20-Day Relative Strength | 79.46 | 45.62 | 48.07 | 51.20 | 53.12 |
| Weighted Alpha | +13.50 | +30.43 | +20.62 | +38.74 | +10.42 |
| Today's Opinion | 100% Buy | 56% Buy | 80% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 03/10/26 | -1.90% since 03/10/26 | -3.81% since 03/10/26 | -2.80% since 03/10/26 | -0.70% since 03/10/26 |
| Low | 114.26 on 03/12/26 | 189.43 on 03/13/26 | 359.80 on 03/17/26 | 142.68 on 03/16/26 | 58.32 on 03/12/26 |
| High | 114.62 on 03/17/26 | 194.83 on 03/11/26 | 380.14 on 03/11/26 | 149.30 on 03/11/26 | 60.81 on 03/17/26 |
| 1-Month | |||||
| %Chg | +63.13% since 02/17/26 | -8.68% since 02/17/26 | -3.28% since 02/17/26 | -7.00% since 02/17/26 | -1.06% since 02/17/26 |
| Low | 63.15 on 02/20/26 | 189.35 on 03/09/26 | 359.80 on 03/17/26 | 142.68 on 03/16/26 | 58.32 on 03/12/26 |
| High | 114.80 on 03/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | +76.95% since 12/17/25 | +6.44% since 12/17/25 | +10.77% since 12/17/25 | +18.98% since 12/17/25 | +11.50% since 12/17/25 |
| Low | 60.35 on 01/05/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 114.80 on 03/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +49.86% since 09/17/25 | +23.11% since 09/17/25 | +31.46% since 09/17/25 | +28.63% since 09/17/25 | +29.38% since 09/17/25 |
| Low | 60.35 on 01/05/26 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 114.80 on 03/06/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,696,544 | 297,789,824 | 197,433,664 | 180,266,752 | 121,597,856 |
| Shares Outstanding, K | 58,480 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 22,290,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -228,930,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 1,650,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -58,110,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.22 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.01 on 02/26/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/14/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.73 | 16.76 | 17.79 | 9.61 |